A randomized controlled study of mesalamine after acute diverticulitis: Results of the DIVA trial Academic Article uri icon

Overview

MeSH Major

  • Anti-Inflammatory Agents, Non-Steroidal
  • Colonic Diseases
  • Diverticulitis
  • Mesalamine
  • Probiotics

abstract

  • In the first US randomized placebo-controlled trial of anti-inflammatory treatment after a documented case of diverticulitis, mesalamine demonstrated a consistent trend in reducing symptoms. Addition of probiotic did not increase mesalamine efficacy. This study supports further investigation into the use of anti-inflammatory agents, such as mesalamine, in the long-term management of diverticulitis. ClinicalTrials.gov NCT00554099.

publication date

  • August 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/MCG.0b013e31828003f6

PubMed ID

  • 23426454

Additional Document Info

start page

  • 621

end page

  • 9

volume

  • 47

number

  • 7